期刊
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
卷 46, 期 1, 页码 98-103出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/00365521.2010.510574
关键词
Galactose elimination capacity; hepatobiliary; liver metabolism; nuclear hepatology; physiology
资金
- NIH [R01 DK074419-01]
- Danish Medical Research Council [271-06-0357]
- Danish Cancer Society [DP06114]
- Aarhus University Foundation
- Novo Nordisk Foundation
- A.P. Moller Foundation for the Advancement of Medical Science
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074419] Funding Source: NIH RePORTER
Objective. A PET method is developed for non-invasive measurement of regional metabolic liver function using the galactose analog 2-[F-18]fluoro-2-deoxy-n-galactose, FDGal. The aim of the present study was to determine the reproducibility of the method in pigs before translating it to human studies. Material and methods. Five anesthetized pigs were studied twice within an interval of three days. A dynamic PET recording was performed with an injection of 100 MBq FDGal. Nonradioactive galactose was administered throughout the PET recordings to achieve near-saturated elimination kinetics. Arterial blood samples were collected for determination of blood concentrations of FDGal and galactose (c(gal)). Net metabolic clearance of FDGal, K-FDGal, was calculated from linear representation of data. The approximate maximal hepatic removal rate, V-max of galactose (mmol/l tissue/min) was calculated as K-FDGal c(gal). The estimates from Day 1 and Day 2 were compared and the coefficient of variation, COV, of the estimates calculated. Functional heterogeneity in normal pig liver was evaluated as COV of the tissue concentration of radioactivity during quasi steady-state metabolism. Results. There was no significant difference between V-max from Day 1 and Day 2 (p = 0.38), and the reproducibility was good with a COV of 14% for the whole liver. In normal pig liver tissue, mean COV after an injection of FDGal was on average 15.6% with no day-to-day variation (p = 0.7). Conclusions. The novel FDGal PET method for determination of hepatic metabolic function has a good reproducibility and is promising for future human studies of regional liver function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据